Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-23
    E.g., 2018-09-23

Articles

12317 items
12:04 PM, Sep 06, 2018  |  BC Extra | Financial News

Liquid biopsy company Guardant files for NASDAQ IPO

Guardant Health Inc. (Redwood City, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by J.P. Morgan, BofA Merrill Lynch, Cowen, Leerink and William Blair. The liquid biopsy company’s last venture...
7:56 AM, Sep 06, 2018  |  BC Extra | Financial News

Zai raises $150M in follow-on

Zai Lab Ltd. (NASDAQ:ZLAB) raised $150 million through the sale of 7.5 million ADSs at $20 in a follow-on. Underwriters are J.P. Morgan, Citigroup, Jefferies and Leerink. The price is a 12% discount to Zai's closing...
4:30 PM, Sep 05, 2018  |  BC Extra | Financial News

Seidenberg, Harper launch Westlake with $320M inaugural fund

Kleiner Perkins’ Beth Seidenberg launched a life science investment firm Wednesday, dubbed Westlake Village BioPartners, with $320 million in committed capital for its first fund. Sean Harper, EVP and head of R&D at Amgen Inc....
9:28 AM, Sep 05, 2018  |  BC Extra | Financial News

Adaptimmune raises $100M via registered direct offering

Adaptimmune Therapeutics plc (NASDAQ:ADAP) raised $100 million through the sale of 10 million ADSs at $10 in a registered direct offering to Matrix Capital Management, New Enterprise Associates and Syncona Ltd. (LSE:SYNC). The price is...
5:01 AM, Sep 05, 2018  |  BC Extra | Financial News

4D Molecular raises $90M series B

Gene therapy company 4D Molecular Therapeutics Inc. (Emeryville, Calif.) raised $90 million in an untranched series B round led by new investor Viking Global Investors. Fellow new investors ArrowMark Partners, Janus Henderson Investors, The Biotechnology...
4:02 AM, Sep 05, 2018  |  BC Extra | Financial News

Fulcrum raises $80M series B

Fulcrum Therapeutics Inc. (Cambridge, Mass.) raised $80 million in an untranched series B round led by Foresite Capital. Also participating were fellow new investors Fidelity, 6 Dimensions Capital, Casdin Capital, Sanofi Venture, Section 32, NS...
4:29 PM, Sep 04, 2018  |  BC Extra | Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

Ahren Innovation Capital LLP (Cambridge, U.K.) announced the first close of its Ahren LP fund with over $100 million from Aviva, Wittington Investments and undisclosed U.S. family offices. The fund declined to disclose the exact...
3:36 PM, Sep 04, 2018  |  BC Extra | Financial News

New role at Arix for Anderson; Ovid's Werber joining Cowen

Arix Bioscience plc (LSE:ARIX) said Joe Anderson will step down as CEO and become chief investment officer to focus on new investments and work with existing group companies to build and create value. Anderson, who...
3:34 PM, Sep 04, 2018  |  BC Extra | Financial News

Another C-suite departure at Immunocore

Chief Strategy and Business Officer Kevin Pojasek has left Immunocore Ltd. (Abingdon, U.K.) to join SV Health Investors as venture partner. Pojasek is the fifth C-level executive to leave the TCR company since former CEO...
5:45 PM, Sep 03, 2018  |  BC Extra | Financial News

Exosome play Evox aims for clinic with £35.5M series B

Evox Therapeutics Ltd. (Oxford, U.K.) raised £35.5 million ($45.9 million) in a series B round led by Redmile Group. Also participating were GV, Cowen Healthcare Investments, Panacea Healthcare Venture, Borealis Ventures, Oxford Sciences Innovation (OSI),...

Pages